CABG Versus PCI in the Treatment of Diabetic Patients Affected by Coronary Artery Disease
-
- Nicolini Francesco
- Cardiac Surgery Unit, Department of Clinical and Experimental Medicine, University of Parma
-
- Agostinelli Andrea
- Cardiac Surgery Unit, Cardio-Nephro-Pulmonary Department, Parma Hospital
-
- Vezzani Antonella
- Cardiac Surgery Unit, Cardio-Nephro-Pulmonary Department, Parma Hospital
-
- Benassi Filippo
- Cardiac Surgery Unit, Cardio-Nephro-Pulmonary Department, Parma Hospital
-
- Gherli Tiziano
- Cardiac Surgery Unit, Department of Clinical and Experimental Medicine, University of Parma
書誌事項
- タイトル別名
-
- Which is the Best Option?
この論文をさがす
説明
Surgical coronary revascularization and percutaneous coronary intervention were demonstrated to be effective treatments for coronary artery disease. However, the optimal revascularization strategy remains unclear in certain patient subsets. The recently published Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM) trial is a randomized study evaluating the use of CABG versus PCI in diabetic patients with multivessel coronary disease. The purpose of this study was to review the available literature based on randomized trials and observational studies in order to allow clinicians to make evidence-based decisions when treating diabetic patients with multivessel coronary disease. The current evidence suggests that CABG should remain the standard of care for this patient population.
収録刊行物
-
- International Heart Journal
-
International Heart Journal 55 (6), 469-473, 2014
一般社団法人 インターナショナル・ハート・ジャーナル刊行会